Form 4: Repligen Corp Director Glenn P Muir Reports Acquisition of Restricted Stock Units and Stock Options

Director Glenn P Muir reports acquisition of 701 restricted stock units and 1,376 stock options in Repligen Corp.

Summary

• On May 16, 2024, Glenn P Muir, a director of Repligen Corp, acquired 701 restricted stock units (RSUs) and 1,376 stock options.
• The RSUs vest on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders.
• Each RSU represents a contingent right to receive one share of Repligen Corporation's Common Stock.
• The stock options have an exercise price of $171.03 and expire on May 16, 2034.
• The stock options vest in full on the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders.
• Following these transactions, Mr. Muir directly owns 8,283 shares of Repligen Corp common stock and 1,376 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option awards to a director, which is a common practice. It doesn't indicate any significant positive or negative development for the company.

Positives

• The acquisition of restricted stock units and stock options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units and stock options is contingent upon future events, specifically the earlier of May 16, 2025, or the date of the next annual meeting of the company's shareholders, which has not yet been determined.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the biotechnology industry, used to align management's interests with those of shareholders.
• Companies like Thermo Fisher Scientific and Danaher also use similar equity-based compensation plans for their executives.
• The vesting schedules and exercise prices are generally in line with industry standards for companies of Repligen's size and stage of development.

Stakeholder Impact

• The acquisition of stock options and restricted stock units by a director can be viewed positively by shareholders as it aligns management's interests with theirs.

Key Dates